기능성 식도장애 = Functional Esophageal Disorders

다국어 초록 (Multilingual Abstract)

Functional esophageal disorders represent processes accompanied by typical esophageal symptoms (heartburn, chest pain, dysphagia, globus) that have no readily identified structural disorders, gastroesophageal reflux disease (GERD), histopathology-based esophageal motor disturbances. GERD is the preferred diagnosis when reflux esophagitis or pathologic acid exposure is present or when typical symptoms are closely related to acid reflux or respond to proton pump inhibitor (PPI) test. A well-defined pathogenetic mechanism is unavailable for any of these disorders; combinations of sensory and motor abnormalities involving both central and peripheral are. Treatments remain empirical and management approaches that modulate central symptom perception or amplification often are required. (JKDS 2011;1:67-71)

참고문헌 (Reference)

1 김정환, "한국의 비심인성 흉통의 진단 및 치료의 고유한 특징" 대한내과학회 80 (80): 649-655, 2011

2 Drossman DA, "U.S. householders survey of functional gastrointestinal disorders. Prevalen ce, sociodemography and health impact" 38 : 1569-1580, 1993

3 Drossman DA, "The functional gastrointestinal disorders and the Rome III process" 130 : 1377-1390, 2006

4 Fass R, "The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain" 115 : 42-49, 1998

5 Sinn DH, "Response rate and predictors of response in a short-term empirical trial of high-dose rabeparazole in patients with globus" 27 : 1275-1281, 2008

6 Timon C, "Globus pharyngeus : long-term follow-up and prognostic factors" 100 : 351-354, 1991

7 Faybush EM, "Gastroesophageal reflux disease in noncardiac chest pain" 33 : 41-54, 2004

8 Galmiche JP, "Functional esophageal disorders" 130 : 1459-1465, 2006

9 Clouse RE, "Functional esophageal disorders" 45 (45): II31-II36, 1999

10 Lee H, "Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain : a randomized, double-blind, placebo-controlled, crossover trial" 105 : 1504-1512, 2010

11 Lee KJ, "Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group" 79 : 131-136, 2009

12 Kim JH, "Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients" 24 : 1504-1509, 2009

13 Kim JH, "Clinical usefulness of subgrouping of patients with non-cardiac chest pain according to characteristic symptoms in Korea" 22 : 320-325, 2007